Introduction Obesity and diabetes are two of India’s most urgent health crises, affecting millions. Eli Lilly, a global pharmaceutical leader, is addressing this challenge with Mounjaro (tirzepatide), a groundbreaking dual-action drug for weight loss and diabetes management. In this blog, we explore…